52 research outputs found
No preconscious attentional bias towards itch in healthy individuals
Rapidly attending towards potentially harmful stimuli to prevent possible damage to the body is a critical component of adaptive behavior. Research suggests that individuals display an attentional bias, i.e., preferential allocation of attention, for consciously perceived bodily sensations that signal potential threat, like itch or pain. Evidence is not yet clear whether an attentional bias also exists for stimuli that have been presented for such a short duration that they do not enter the stream of consciousness. This study investigated whether a preconscious attentional bias towards itch-related pictures exists in 127 healthy participants and whether this can be influenced by priming with mild itch-related stimuli compared to control stimuli. Mild itch was induced with von Frey monofilaments and scratching sounds, while control stimuli where of matched modalities but neutral. Attentional bias was measured with a subliminal pictorial dot-probe task. Moreover, we investigated how attentional inhibition of irrelevant information and the ability to switch between different tasks, i.e., cognitive flexibility, contribute to the emergence of an attentional bias. Attentional inhibition was measured with a Flanker paradigm and cognitive flexibility was measured with a cued-switching paradigm. Contrary to our expectations, results showed that participants attention was not biased towards the itch-related pictures, in facts, attention was significantly drawn towards the neutral pictures. In addition, no effect of the itch-related priming was observed. Finally, this effect was not influenced by participants' attentional inhibition and cognitive flexibility. Therefore, we have no evidence for a preconscious attentional bias towards itch stimuli. The role of preconscious attentional bias in patients with chronic itch should be investigated in future studies
Recommended from our members
Myocardial Infarction Accelerates Atherosclerosis
During progression of atherosclerosis, myeloid cells destabilize lipid-rich plaque in the arterial wall and cause its rupture, thus triggering myocardial infarction and stroke. Survivors of acute coronary syndromes have a high risk of recurrent events for unknown reasons. Here we show that the systemic response to ischemic injury aggravates chronic atherosclerosis. After myocardial infarction or stroke, apoE mice developed larger atherosclerotic lesions with a more advanced morphology. This disease acceleration persisted over many weeks and was associated with markedly increased monocyte recruitment. When seeking the source of surplus monocytes in plaque, we found that myocardial infarction liberated hematopoietic stem and progenitor cells from bone marrow niches via sympathetic nervous system signaling. The progenitors then seeded the spleen yielding a sustained boost in monocyte production. These observations provide new mechanistic insight into atherogenesis and provide a novel therapeutic opportunity to mitigate disease progression
Microestrutura de pĂȘlos-guarda de felĂdeos Brasileiros: consideraçÔes para a identificação de espĂ©cies
Recommended from our members
COURSE IN THE THEORY AND DESIGN OF PARTICLE ACCELERATORS - LECTURE 11
Lab and field studies into effectiveness of flat steel plate â Rubber pad systems as tyre substitutes for local loading of cellular GFRP bridge decking
Development and validation of the General Attitude towards Medication Questionnaire (GAMQ)
Objective: Attitudes towards medication can affect treatment outcomes and adherence through mechanisms such as placebo and nocebo effects. Questionnaires assessing both negative and positive attitudes towards medication in general are however lacking. To fill this gap, we developed and validated the General Attitude towards Medication Questionnaire (GAMQ).
Methods: Items were selected and adapted from existing questionnaires by a group of experts. Validation of the original Dutch version took place in 4 samples: 2 recruited from the general population and 2 patient samples. We evaluated the psychometric properties of the GAMQ by determining the factor structure and its stability across samples, internal consistency, and convergent validity.
Results: The GAMQ contains 6 positive and 6 negatively worded items. A factor structure was observed with three subscales, representing âTrust in medicationâ, âConcerns about medicationâ, and âReluctance to use medicationâ. The fit of the factor structure was satisfactory across samples with an adequate or close to adequate fit. The total scale showed good internal consistency, convergent, and concurrent validity.
Conclusion: The newly developed GAMQ showed satisfactory psychometric properties in a variety of populations. The GAMQ is the first scale to assess both positive and negative attitudes towards medication in general and might be an informative measure for predicting treatment outcomes, adherence, as well as placebo and nocebo effects
- âŠ